CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition

EI Buchbinder, A Desai - American journal of clinical oncology, 2016 - journals.lww.com
The cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1)
immune checkpoints are negative regulators of T-cell immune function. Inhibition of these …

Nanotechnology-empowered strategies in treatment of skin cancer

J Chandra, N Hasan, N Nasir, S Wahab… - Environmental …, 2023 - Elsevier
In current scenario skin cancer is a serious condition that has a significant impact on world
health. Skin cancer is divided into two categories: melanoma skin cancer (MSC) and non …

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)

J Schachter, A Ribas, GV Long, A Arance, JJ Grob… - The Lancet, 2017 - thelancet.com
Background Interim analyses of the phase 3 KEYNOTE-006 study showed superior overall
and progression-free survival of pembrolizumab versus ipilimumab in patients with …

Overall survival in patients with advanced melanoma who received nivolumab versus investigator's choice chemotherapy in CheckMate 037: a randomized, controlled …

J Larkin, D Minor, S D'Angelo, B Neyns… - Journal of clinical …, 2018 - ascopubs.org
Purpose Until recently, limited options existed for patients with advanced melanoma who
experienced disease progression while receiving treatment with ipilimumab. Here, we report …

Inhibition of immune checkpoints and vascular endothelial growth factor as combination therapy for metastatic melanoma: an overview of rationale, preclinical …

PA Ott, FS Hodi, EI Buchbinder - Frontiers in oncology, 2015 - frontiersin.org
The role of angiogenesis as a mediator of immune regulation in the tumor microenvironment
has recently come into focus. Furthermore, emerging evidence indicates that …

Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade

E Buchbinder, FS Hodi - The Journal of clinical investigation, 2015 - Am Soc Clin Investig
The relationship between cancer and the immune system is complex and provides unique
therapeutic opportunities. Cytotoxic T lymphocyte antigen-4 (CTLA-4) is a regulatory …

Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma

HH Cao, JH Chu, HY Kwan, T Su, H Yu, CY Cheng… - Scientific reports, 2016 - nature.com
Signal transducer and activator of transcription 3 (STAT3) signaling is constantly activated in
human melanoma, and promotes melanoma metastasis. The dietary flavonoid apigenin is a …

Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma

R Iannone, L Miele, P Maiolino, A Pinto, S Morello - Neoplasia, 2013 - Elsevier
The A 2b receptor (A 2b R) belongs to the adenosine receptor family. Emerging evidence
suggest that A 2b R is implicated in tumor progression in some murine tumor models, but the …

Natural killer cells and regulatory T cells cross talk in hepatocellular carcinoma: exploring therapeutic options for the next decade

AG Bozward, F Warricker, YH Oo… - Frontiers in …, 2021 - frontiersin.org
Despite major advances in immunotherapy, hepatocellular carcinoma (HCC) remains a
challenging target. Natural Killer (NK) cells are crucial components of the anti-HCC immune …

Bringing natural killer cells to the clinic: ex vivo manipulation

RW Childs, M Berg - Hematology 2013, the American Society …, 2013 - ashpublications.org
Recently, there has been a substantial gain in our understanding of the role that natural
killer (NK) cells play in mediating innate host immune responses against viruses and cancer …